Biotalys is a rapidly growing and transformative food and crop protection company developing a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply.
Crop protection products (e.g. insecticides, fungicides) with AgrobodiesTM as formulation agents (antibody fragments from camel antibodies) can be used at lower dosages or have a longer lasting effect without repeat applications and thereby contribute to improved and more sustainable agricultural production.
Based on its ground-breaking technology platform, the company is developing a broad pipeline of effective and safe products with novel modes of action, addressing key crop pests and diseases across the whole value chain, from soil to plate.
Biotalys’ unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. The company is on track to launch its first biofungicide in the USA in 2022, followed by subsequent market introductions globally.
Founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology), Biotalys has raised EUR 51 million to date from specialist international investors. The company is based in the biotech cluster in Ghent, Belgium.